With so many avenues to invest in, why not take a look into something that affects everyone?

While doing my daily research into an ever growing stock market, I noticed a healthcare stock that needed more investigating. NeoPharm originally caught my eye by being listed in the insider trading news. At a low price of around $8.00 a share, it was priced right. It is now time to do my homework.

I started my investigation at the research center of my stock trading firm. I quickly learned that NeoPharm was a company dedicated to research and discovery of new cancer drugs. This intrigued me immediately. There are not many people in this world that cancer has not affected directly or indirectly. NeoPharm is based in Waukegan , Illinois and is traded on the NASDAQ exchange. After studying the basic charts and learning of a press release. I wanted more. My next step was to visit their website.

Read more in Investing
« Will Youtube go down as fast as it came up?
Time to put the Boot in your Portfolio »

At my favorite search engine, I typed in NeoPharm and found the site quickly. NeoPharm impressed me even more. NeoPharm has many innovative drugs in many different stages, but one really caught my eye. Cintredekin Besudotox is designed to attach unhealthy cancer cells and not harm healthy cells. The drug is currently in a Phase III chemical trial and has received fast-track drug development program status from the FDA.

After finishing my investigation, I decided NeoPharm would be a nice addition to my portfolio. The dedication and commitment to fight cancer, along with there progress gave me a warm feeling. It’s nice to know that there are possibilities of having a drug for fighting such a deadly illness. As always, research should be done by the investor or brokerage firm before deciding to invest in anything.